Welcome to LookChem.com Sign In|Join Free

CAS

  • or

62054-49-3

Post Buying Request

62054-49-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

62054-49-3 Usage

Chemical Properties

Light Yellow Oil

Uses

Derivative of monoenoic and trienoic analogs of Sorbic Acid with antifungal activity.

Check Digit Verification of cas no

The CAS Registry Mumber 62054-49-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,0,5 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 62054-49:
(7*6)+(6*2)+(5*0)+(4*5)+(3*4)+(2*4)+(1*9)=103
103 % 10 = 3
So 62054-49-3 is a valid CAS Registry Number.

62054-49-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 3-methyl-4-oxocrotonate

1.2 Other means of identification

Product number -
Other names ethyl (E)-3-methyl-4-oxobut-2-enoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:62054-49-3 SDS

62054-49-3Synthetic route

ethyl (E)-4-hydroxy-3-methyl-2-butenoate
65527-85-7

ethyl (E)-4-hydroxy-3-methyl-2-butenoate

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With manganese(IV) oxide In dichloromethane at 25℃; for 1h;92%
With manganese(IV) oxide In dichloromethane for 3h; Ambient temperature;79%
With manganese(IV) oxide; calcium sulfate In dichloromethane for 1h; Ambient temperature;72%
ethyl (E/Z)-4,4-dimethoxy-3-methylbut-2-enoate
83803-81-0

ethyl (E/Z)-4,4-dimethoxy-3-methylbut-2-enoate

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With hydrogenchloride In dichloromethane for 1.5h;78%
With sulfuric acid In water70%
With hydrogenchloride In 1,4-dioxane for 4h; Ambient temperature;53%
(E)-4,4-Dimethoxy-3-methyl-crotonsaeureaethylester
65527-84-6

(E)-4,4-Dimethoxy-3-methyl-crotonsaeureaethylester

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With sodium acetate In water; acetic acid for 3.5h; Heating;69.8%
With hydrogenchloride In dichloromethane; water at 0℃; for 2h; Inert atmosphere;
ethyl (E)-4-bromo-3-methyl-2-butenoate
51318-62-8

ethyl (E)-4-bromo-3-methyl-2-butenoate

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With sulfuric acid In water42%
ethyl 2-ethoxyglycolate
49653-17-0

ethyl 2-ethoxyglycolate

propionaldehyde
123-38-6

propionaldehyde

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With dibutylamine
3-Methyl-4--crotonsaeureethylester
97361-72-3

3-Methyl-4--crotonsaeureethylester

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With sulfuric acid
4-hydroxy-3-methyl-trans(?)-crotonic acid ethyl ester

4-hydroxy-3-methyl-trans(?)-crotonic acid ethyl ester

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With manganese(IV) oxide; Petroleum ether
diethoxyphosphoryl-acetic acid ethyl ester
867-13-0

diethoxyphosphoryl-acetic acid ethyl ester

Pyruvic aldehyde dimethyl acetal
6342-56-9

Pyruvic aldehyde dimethyl acetal

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
Stage #1: diethoxyphosphoryl-acetic acid ethyl ester; Pyruvic aldehyde dimethyl acetal With sodium hydride In N,N-dimethyl-formamide at 0℃; for 1h;
Stage #2: With hydrogenchloride; water In dichloromethane at 20℃; for 3h;
ethyl 3-methylbut-2-enoate
638-10-8

ethyl 3-methylbut-2-enoate

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 90 percent / SeO2 / aq. ethanol / 24 h / Heating
2: 72 percent / CaSO4, MnO2 / CH2Cl2 / 1 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: N-bromosuccinimide, d'acide m-chloroperbenzoique / CCl4
2: 42 percent / H2SO4 / H2O
View Scheme
Multi-step reaction with 3 steps
1: Br2
2: (i) Py, (ii) /BRN= 607293/, NaOH
3: aq. H2SO4
View Scheme
β,γ-epoxy-isovaleric acid ethyl ester
344248-78-8

β,γ-epoxy-isovaleric acid ethyl ester

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hexamethylphosphoric amide / 2 h / Ambient temperature
2: 79 percent / activated MnO2 / CH2Cl2 / 3 h / Ambient temperature
View Scheme
ethyl 4-bromo-3-methylcrotonate
51318-62-8, 51371-55-2, 26918-14-9

ethyl 4-bromo-3-methylcrotonate

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (i) Py, (ii) /BRN= 607293/, NaOH
2: aq. H2SO4
View Scheme
diethyl (2R,3R)-tartrate
87-91-2

diethyl (2R,3R)-tartrate

2-(triphenylphosphoranylidene)propionaldehyde
24720-64-7

2-(triphenylphosphoranylidene)propionaldehyde

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Conditions
ConditionsYield
With NaIO4 on SiO2 In dichloromethane at 20℃;
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

acetic anhydride
108-24-7

acetic anhydride

(E)-ethyl 3-methyl-4-diacetoxycrotonate
283179-31-7

(E)-ethyl 3-methyl-4-diacetoxycrotonate

Conditions
ConditionsYield
With iron(III) chloride at 0℃; for 0.5h;99%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

ethyl (E)-4-hydroxy-3-methyl-2-butenoate
65527-85-7

ethyl (E)-4-hydroxy-3-methyl-2-butenoate

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 20℃;98%
With sodium tetrahydroborate In methanol at 0 - 20℃; for 16h; chemoselective reaction;90%
With sodium tetrahydroborate In ethanol for 0.25h;3.9 g
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

ethylene glycol
107-21-1

ethylene glycol

ethyl (E)-4,4-ethylenedioxy-3-methylbut-2-enoate
65527-87-9

ethyl (E)-4,4-ethylenedioxy-3-methylbut-2-enoate

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate In benzene for 4h; Heating;91%
With pyridinium p-toluenesulfonate89%
With pyridinium p-toluenesulfonate In benzene for 12h; Heating;
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(7E)-9-ethynyl-β-ionol
17974-59-3

(7E)-9-ethynyl-β-ionol

ethyl 9-(2',6',6'-trimethyl-1'-cyclohexen-1'-yl)-3,7-dimethyl-4,7-dihydroxy-(2E,8E)-nona-2,8-dien-5-ynoate
95286-43-4, 118304-67-9, 118333-95-2

ethyl 9-(2',6',6'-trimethyl-1'-cyclohexen-1'-yl)-3,7-dimethyl-4,7-dihydroxy-(2E,8E)-nona-2,8-dien-5-ynoate

Conditions
ConditionsYield
With ethylmagnesium bromide90%
With ethylmagnesium bromide 1.) THF, room temperature, 1 h, 2.) THF, 15 min; Yield given. Multistep reaction;
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(3,7-dimethyl-2,6-octadienyl)-triphenylphosphonium bromide
41273-34-1

(3,7-dimethyl-2,6-octadienyl)-triphenylphosphonium bromide

ethyl (2E,4E,6E)-3,7,11-trimethyldodeca-2,4,6,10-tetraenoate
29448-58-6, 37384-80-8, 51010-81-2, 51010-78-7

ethyl (2E,4E,6E)-3,7,11-trimethyldodeca-2,4,6,10-tetraenoate

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran at 20℃; Condensation; Wittig reaction;90%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(2R,3R)-ethyl 4-(benzyldimethylsilyl)-2-hydroxy-3-(trimethylsilyl)pent-4-enoate

(2R,3R)-ethyl 4-(benzyldimethylsilyl)-2-hydroxy-3-(trimethylsilyl)pent-4-enoate

ethyl 4-(benzyldimethylsilyl)-6-((E)-4-ethoxy-4-oxobut-2-en-2-yl)-5,6-dihydro-2H-pyran-2-carboxylate

ethyl 4-(benzyldimethylsilyl)-6-((E)-4-ethoxy-4-oxobut-2-en-2-yl)-5,6-dihydro-2H-pyran-2-carboxylate

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at -20℃; for 1.5h; Inert atmosphere; diastereoselective reaction;90%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Methyltriphenylphosphonium bromide
1779-49-3

Methyltriphenylphosphonium bromide

methyl-3 pentadiene-2,4 oate d'ethyle E
37850-26-3

methyl-3 pentadiene-2,4 oate d'ethyle E

Conditions
ConditionsYield
Stage #1: Methyltriphenylphosphonium bromide With n-butyllithium In tetrahydrofuran; hexane at -78 - 0℃; for 1h; Schlenk technique;
Stage #2: ethyl (E)-3-formyl-2-butenoate In tetrahydrofuran; hexane at 0℃; for 0.5h; Schlenk technique;
89%
Stage #1: Methyltriphenylphosphonium bromide With n-butyllithium In tetrahydrofuran; hexane at -78 - 0℃; Wittig reaction;
Stage #2: ethyl (E)-3-formyl-2-butenoate In tetrahydrofuran; hexane at -78 - 20℃; Wittig reaction;
83%
Stage #1: Methyltriphenylphosphonium bromide With n-butyllithium In tetrahydrofuran; hexane at -78 - 0℃; for 1h;
Stage #2: ethyl (E)-3-formyl-2-butenoate In tetrahydrofuran; hexane at -78 - 20℃; for 10h;
40%
Stage #1: Methyltriphenylphosphonium bromide With n-butyllithium In tetrahydrofuran; hexane at -78 - 110℃; Inert atmosphere;
Stage #2: ethyl (E)-3-formyl-2-butenoate In tetrahydrofuran; hexane at -45℃; Inert atmosphere;
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

1-bromo-2-ethyl-3,4-dimethoxybenzene
1353851-85-0

1-bromo-2-ethyl-3,4-dimethoxybenzene

(E) ethyl 4-(2-ethyl-3,4-dimethoxyphenyl)-4-hydroxy-3-methylbut-2-enoate

(E) ethyl 4-(2-ethyl-3,4-dimethoxyphenyl)-4-hydroxy-3-methylbut-2-enoate

Conditions
ConditionsYield
Stage #1: 1-bromo-2-ethyl-3,4-dimethoxybenzene With ethyl bromide; iodine; magnesium In tetrahydrofuran for 1h; Reflux;
Stage #2: ethyl (E)-3-formyl-2-butenoate In tetrahydrofuran at 0 - 20℃; for 12h;
Stage #3: With hydrogenchloride In tetrahydrofuran; water
89%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(5Z,7E)-(1S,3R)-1,3-bis[(t-butyldimethyl-silyl)oxy]-24-phenylsulfonyl-22,23-dinor-9,10-secochola-5,7,10(19)-triene
223538-02-1

(5Z,7E)-(1S,3R)-1,3-bis[(t-butyldimethyl-silyl)oxy]-24-phenylsulfonyl-22,23-dinor-9,10-secochola-5,7,10(19)-triene

ethyl (5Z,7E,23aE)-(1S,3R)-1,3-bis[(t-butyldimethylsilyl)oxy]-22-phenylsulfonyl-23-hydroxy-23a-methyl-23a,23b-dihomo-9,10-secochola-5,7,10(19),23-tetraene-24-oate

ethyl (5Z,7E,23aE)-(1S,3R)-1,3-bis[(t-butyldimethylsilyl)oxy]-22-phenylsulfonyl-23-hydroxy-23a-methyl-23a,23b-dihomo-9,10-secochola-5,7,10(19),23-tetraene-24-oate

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran at -70℃; for 0.25h;88%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

4-methoxyphenylhydrazine hydrochloride
19501-58-7

4-methoxyphenylhydrazine hydrochloride

(2E,4E)-4-[2-(4-methoxyphenyl)hydrazono]-3-methyl-2-butenoic acid ethyl ester

(2E,4E)-4-[2-(4-methoxyphenyl)hydrazono]-3-methyl-2-butenoic acid ethyl ester

Conditions
ConditionsYield
With pyridine at 20℃; for 0.5h;87%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

hex-1-yne
693-02-7

hex-1-yne

ethyl (E)-4-hydroxy-3-methyldec-2-en-5-ynoate

ethyl (E)-4-hydroxy-3-methyldec-2-en-5-ynoate

Conditions
ConditionsYield
Stage #1: hex-1-yne With n-butyllithium In tetrahydrofuran; hexane for 1h; Inert atmosphere; Cooling with acetone-dry ice;
Stage #2: ethyl (E)-3-formyl-2-butenoate In tetrahydrofuran; hexane at 20℃; Inert atmosphere;
86%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

C41H65NO4S2Si2

C41H65NO4S2Si2

C41H70O4Si2

C41H70O4Si2

Conditions
ConditionsYield
With lithium hexamethyldisilazane Julia Olefin Synthesis;85%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(S)-p-toluenesulfinimide
188447-91-8

(S)-p-toluenesulfinimide

C14H17NO3S

C14H17NO3S

Conditions
ConditionsYield
With titanium(IV) tetraethanolate In dichloromethane for 6h; Inert atmosphere; Reflux;84%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

[(2E,4E)-5-(2-Acetoxymethyl-6,6-dimethyl-cyclohex-1-enyl)-3-methyl-penta-2,4-dienyl]-triphenyl-phosphonium; bromide
81121-47-3

[(2E,4E)-5-(2-Acetoxymethyl-6,6-dimethyl-cyclohex-1-enyl)-3-methyl-penta-2,4-dienyl]-triphenyl-phosphonium; bromide

A

(2E,4E,6E,8E)-9-(2-Hydroxymethyl-6,6-dimethyl-cyclohex-1-enyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid ethyl ester
81121-49-5, 81176-72-9

(2E,4E,6E,8E)-9-(2-Hydroxymethyl-6,6-dimethyl-cyclohex-1-enyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid ethyl ester

B

(2E,4Z,6E,8E)-9-(2-Acetoxymethyl-6,6-dimethyl-cyclohex-1-enyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid ethyl ester
81121-48-4

(2E,4Z,6E,8E)-9-(2-Acetoxymethyl-6,6-dimethyl-cyclohex-1-enyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid ethyl ester

C

ethyl (2E,4E,6E,8E)-9-<2-(acetoxymethyl)-6,6-dimethyl-1-cyclohexen-1-yl>-3,7-dimethyl-2,4,6,8-nonatetraenoate
81176-71-8

ethyl (2E,4E,6E,8E)-9-<2-(acetoxymethyl)-6,6-dimethyl-1-cyclohexen-1-yl>-3,7-dimethyl-2,4,6,8-nonatetraenoate

Conditions
ConditionsYield
With sodium methylate In methanol; dichloromethane at 0 - 5℃; for 0.166667h;A n/a
B n/a
C 81%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

acetone
67-64-1

acetone

ethyl (E)-4-hydroxy-3-methyl-6-oxohept-2-enoate

ethyl (E)-4-hydroxy-3-methyl-6-oxohept-2-enoate

Conditions
ConditionsYield
With chiral binaphthyl-based amino acid In N,N-dimethyl-formamide at 20℃; for 24h;81%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(2S)-ethoxy-(4S)-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-pyran
596093-06-0

(2S)-ethoxy-(4S)-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-pyran

ethyl-(2E,4R)-4-[(2R,6S)-6-ethoxy-5,6-dihydro-2H-pyran-2-yl]-4-hydroxy-3-methylbut-2-enoate
890527-60-3

ethyl-(2E,4R)-4-[(2R,6S)-6-ethoxy-5,6-dihydro-2H-pyran-2-yl]-4-hydroxy-3-methylbut-2-enoate

Conditions
ConditionsYield
Stage #1: ethyl (E)-3-formyl-2-butenoate; (2S)-ethoxy-(4S)-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-pyran at 50℃; for 5h; Inert atmosphere;
Stage #2: With water; sodium hydrogencarbonate for 0.5h; Inert atmosphere; Saturated solution;
81%
at 25℃; for 24h;476 mg
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalenyl)ethanone
17610-24-1

1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalenyl)ethanone

ethyl (E)-4-hydroxy-3-methyl-6-oxo-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-2-hexenoate
156910-46-2

ethyl (E)-4-hydroxy-3-methyl-6-oxo-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-2-hexenoate

Conditions
ConditionsYield
With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane80%
With n-butyllithium; diisopropylamine 1.) THF, hexane, -78 deg C, 20 min, 2.) THF, hexane, -78 deg C, 35 min; Yield given. Multistep reaction;
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(triphenylphosphoranylidene)acetaldehyde
2136-75-6

(triphenylphosphoranylidene)acetaldehyde

ethyl (2E,4E)-3-methyl-6-oxo-2,4-hexadienoate
35482-69-0

ethyl (2E,4E)-3-methyl-6-oxo-2,4-hexadienoate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 15h; Wittig reaction;80%
In dichloromethane at 20℃; for 15h; optical yield given as %de;80%
In dichloromethane at 20℃; for 14h; Wittig reaction;68%
In dichloromethane at 20℃; for 15h; Inert atmosphere;
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(triphenylphosphoranylidene)acetaldehyde
2136-75-6

(triphenylphosphoranylidene)acetaldehyde

A

ethyl (2E,4E)-3-methyl-6-oxo-2,4-hexadienoate
35482-69-0

ethyl (2E,4E)-3-methyl-6-oxo-2,4-hexadienoate

B

C11H14O3
1221294-61-6

C11H14O3

Conditions
ConditionsYield
In dichloromethane at 20℃; for 15h; Wittig reaction; stereoselective reaction;A 80%
B 2.7%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

A

TRICARBONYL{1-4-η-[(1E,3E)-1-ETHOXYCARBONYL-2-METHYL-5-OXO-1,3-PENTADIENYL]}IRON

TRICARBONYL{1-4-η-[(1E,3E)-1-ETHOXYCARBONYL-2-METHYL-5-OXO-1,3-PENTADIENYL]}IRON

B

ethyl (E)-4-hydroxy-3-methyl-2-butenoate
65527-85-7

ethyl (E)-4-hydroxy-3-methyl-2-butenoate

Conditions
ConditionsYield
A n/a
B 76%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(2S,3R,4R)-2-Ethoxy-3-(3-methyl-but-2-enyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-pyran

(2S,3R,4R)-2-Ethoxy-3-(3-methyl-but-2-enyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-pyran

(E)-(R)-4-[(2R,5R,6S)-6-Ethoxy-5-(3-methyl-but-2-enyl)-5,6-dihydro-2H-pyran-2-yl]-4-hydroxy-3-methyl-but-2-enoic acid ethyl ester
848188-00-1

(E)-(R)-4-[(2R,5R,6S)-6-Ethoxy-5-(3-methyl-but-2-enyl)-5,6-dihydro-2H-pyran-2-yl]-4-hydroxy-3-methyl-but-2-enoic acid ethyl ester

Conditions
ConditionsYield
at 110℃; for 48h;76%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

triphenyl-(2,3,3-trimethyl-cyclohex-1-enylmethyl)-phosphonium; iodide

triphenyl-(2,3,3-trimethyl-cyclohex-1-enylmethyl)-phosphonium; iodide

(2E,4E)-[3-methyl-5-(2',3',3'-trimethylcyclohex-1'-enyl)penta-2,4-dienoate d'ethyle]

(2E,4E)-[3-methyl-5-(2',3',3'-trimethylcyclohex-1'-enyl)penta-2,4-dienoate d'ethyle]

Conditions
ConditionsYield
Stage #1: triphenyl-(2,3,3-trimethyl-cyclohex-1-enylmethyl)-phosphonium; iodide With n-butyllithium In tetrahydrofuran; hexane at -10℃; for 0.25h; Wittig reaction;
Stage #2: ethyl (E)-3-formyl-2-butenoate In tetrahydrofuran; hexane at -10℃; for 5h; Wittig reaction;
Stage #3: With hydrogenchloride In tetrahydrofuran; hexane
75%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

Dimethyl-(3-methyl-but-2-enyl)-sulfonium; chloride
81121-25-7

Dimethyl-(3-methyl-but-2-enyl)-sulfonium; chloride

(E)-3-[3-(2-Methyl-propenyl)-oxiranyl]-but-2-enoic acid ethyl ester
81121-26-8, 81177-14-2

(E)-3-[3-(2-Methyl-propenyl)-oxiranyl]-but-2-enoic acid ethyl ester

Conditions
ConditionsYield
With sodium hydroxide; N-benzyl-N,N,N-triethylammonium chloride In dichloromethane at 0℃; for 0.333333h;74%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

(2S,3R,4R)-2-Ethoxy-3-heptyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-pyran
848187-89-3

(2S,3R,4R)-2-Ethoxy-3-heptyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-pyran

ethyl-(2E,4R)-4-[(2R,5R,6S)-6-ethoxy-5-heptyl-5,6-dihydro-2H-pyran-2-yl]-4-hydroxy-3-methylbut-2-enoate
848187-90-6

ethyl-(2E,4R)-4-[(2R,5R,6S)-6-ethoxy-5-heptyl-5,6-dihydro-2H-pyran-2-yl]-4-hydroxy-3-methylbut-2-enoate

Conditions
ConditionsYield
at 110℃; for 48h;74%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

N,N-diisopropylhydrazine
921-14-2

N,N-diisopropylhydrazine

ethyl (2E, 4E)-4-(2,2-diisopropylhydrazono)-3-methylbut-2-enoate

ethyl (2E, 4E)-4-(2,2-diisopropylhydrazono)-3-methylbut-2-enoate

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane at 23℃; for 24h; Inert atmosphere;74%
ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

1,1-dimethylhydrazine
57-14-7

1,1-dimethylhydrazine

ethyl (2E,4Z)-4-(2,2-dimethylhydrazono)-3-methylbut-2-enoate

ethyl (2E,4Z)-4-(2,2-dimethylhydrazono)-3-methylbut-2-enoate

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane at 23℃; for 24h; Inert atmosphere;74%
2,5,5-trimethylpyrroline N-oxide
4567-18-4

2,5,5-trimethylpyrroline N-oxide

ethyl (E)-3-formyl-2-butenoate
62054-49-3

ethyl (E)-3-formyl-2-butenoate

3-methyl-5-(5,5-dimethyl-1-oxide-4,5-dihydro-3H-pyrrol-2-yl)penta-2,4-dienoic acid ethyl ester

3-methyl-5-(5,5-dimethyl-1-oxide-4,5-dihydro-3H-pyrrol-2-yl)penta-2,4-dienoic acid ethyl ester

Conditions
ConditionsYield
In toluene at 110℃; for 3h;72%

62054-49-3Relevant articles and documents

Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the methylerythritol phosphate pathway

Janthawornpong, Karnjapan,Krasutsky, Sergiy,Chaignon, Philippe,Rohmer, Michel,Poulter, C. Dale,Seemann, Myriam

, p. 1816 - 1822 (2013)

The MEP pathway, which is absent in animals but present in most pathogenic bacteria, in the parasite responsible for malaria and in plant plastids, is a target for the development of antimicrobial drugs. IspH, an oxygen-sensitive [4Fe-4S] enzyme, catalyzes the last step of this pathway and converts (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate (HMBPP) into the two isoprenoid precursors: isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). A crucial step in the mechanism of this enzyme is the binding of the C4 hydroxyl of HMBPP to the unique fourth iron site in the [4Fe-4S]2+ moiety. Here, we report the synthesis and the kinetic investigations of two new extremely potent inhibitors of E. coli IspH where the OH group of HMBPP is replaced by an amino and a thiol group. (E)-4-Mercapto-3-methylbut-2-en-1-yl diphosphate is a reversible tight-binding inhibitor of IspH with Ki = 20 ± 2 nM. A detailed kinetic analysis revealed that (E)-4-amino-3-methylbut-2-en-1-yl diphosphate is a reversible slow-binding inhibitor of IspH with Ki = 54 ± 19 nM. The slow binding behavior of this inhibitor is best described by a one-step mechanism with the slow step consisting of the formation of the enzyme-inhibitor (EI) complex.

Stereospecific Synthesis of the Important Retinoid Synthon Ethyl trans-3-Formyl-2-butenoate via Direct Two-Stage Oxidation of Ethyl 3-Methyl-2-butenoate

Curley, Robert W.,Ticoras, Christ J.

, p. 256 - 258 (1986)

-

A novel catalytic asymmetric route towards skipped dienes with a methyl-substituted central stereogenic carbon

Huang, Yange,Fananas-Mastral, Martin,Minnaard, Adriaan J.,Feringa, Ben L.

supporting information, p. 3309 - 3311 (2013/06/04)

A highly efficient method for the enantioselective synthesis of 1,4-dienes (skipped dienes) with a methyl-substituted central stereogenic carbon using copper-catalysed asymmetric allylic alkylation of diene bromides was developed. Excellent regio- and enantioselectivity (up to 97 : 3 SN2′/ SN2 ratio and 99% ee) were achieved with broad substrate scope. The Royal Society of Chemistry 2013.

Simple, Catalytic Enantioselective Syntheses of Estrone and Desogestrel

Hu, Qi-Ying,Rege, Pankaj D.,Corey

, p. 5984 - 5986 (2007/10/03)

Highly enantioselective and very short syntheses of the bioactive forms of estrone (3) and desogestrel (4) are described using a chiral oxazaborolidinium catalyst (2) in the key initial step. Enantiomerically pure estrone was synthesized in eight steps from the readily available starting materials diene 5 and α,β-enal 6 via intermediates 8 and 9. Desogestrel was synthesized using a similar strategy from diene 5 and α,β-enal 11 via intermediates 12-17. The efficient syntheses of the chiral catalyst 2 and its enantiomer are also presented. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 62054-49-3